Life Sciences
Argos Therapeutics
Natus Medical
Regado Biosciences
Stemco Biomedical
United Emergency Services
Xsira Pharmaceuticals
Information Technology
Healthcare Services/Healthcare IT
All Companies
Life Sciences Printer friendly version

Argos develops immunotherapy treatments for cancer. The technology centers on the use of dendritic cells and tumor RNA which together constitute a vaccine. The research team is based at Duke University Medical Center and has been working on the technology for several years.

Cropsolution is focused on chemical crop protection.  The company will use its proprietary Evolutionary Chemistry technology to discover and develop novel agrochemicals for protecting crops from diseases,weeds, and insect pests, addressing current market opportunities totaling $30B.
HyperBranch Medical Technology, Inc. is a development stage company focused on restoring vision or preventing serious vision loss through the development of new medical devices for ocular surgery. By integrating polymer chemistry and biomedical engineering, the Company has developed unique polymers that possess highly tunable properties.

A public biotechnology company (NASDAQ:ICOR) using proprietary systems biology to discover biomarkers to reduce the cost, risk and time of product development, as well as to discover inaccessible targets for small molecule discovery.  Icoria (formerly Paradigm Genetics) acquired Aurora portfolio company, TissueInformatics in March 2004.

Metabolon is a leader in the application of metabolomics, a new and powerful scientific approach, for the discovery and development of drugs.

Natus is a medical device company that develops, manufactures and markets proprietary, non-invasive medical instruments and related disposables for use in diagnosing diseases in newborn infants and children. Natus had its IPO in July 2001 (NASDAQ: BABY).
Neotropix™, Inc. is a cutting-edge virotherapy company, dedicated to the development and commercialization of virus-based therapies for the treatment of cancer and other diseases. Virotherapy holds great promise for cancer patients because it may be more efficacious and less toxic than conventional radiation and chemotherapy.

Nobex recently developed and proven in animal studies the oral delivery of powerful protein drugs for the treatment of diabetes, cancer, pain, degenerative diseases and possibly certain nervous system disorders.
Regado is an early stage biotechnology company whose vision is to be the world leader in the discovery, development, and commercialization of regulatable therapeutics.  Regulatable therapeutics are designed to enhance physician control and improve patient outcomes.

StemCo commercializes a proprietary reagent that has the ability to select for hematopoietic stem cells (hscs).  The company is using this technology to develop diagnostic and therapeutic uses for hscs in the treatment of cancer and autoimmmune disorders.

TriVirix provides engineering, manufacturing and post-manufacturing logistics of reliable instruments for medical device companies.  The company has a state-of-the-art manufacturing plant in Northern Ireland.

United Emergency Services (UES) is a physician contract management company that focuses on providing experienced emergency department physicians and other health care providers to single hospital communities in the Southeastern United States.

Virologic is a biotechnology company that performs, develops and markets drug susceptibility and resistance tests to be used in optimizing the treatment of patients with serious viral infections. Virologic had its IPO in May 2000 (NASDAQ: VLGC).

Xsira was founded to commercialize a patented platform technology enabling the direct measurement of g protein-coupled receptor activation and subsequent receptor regulation.  The company’s technology can serve as an enabling tool for drug discovery efforts.